CTE is a tauopathy with progressive accumulation of Tau protein (McKee et al., 2009; Stein et al., 2014) and has been delineated as a consequence of repeated mild TBI (Gardner and Yaffe, 2015; Smith et al., 2019; McKee et al., 2023). The gene discussed is MAPT; the disease is tauopathy.